Dr. Richman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3160 Folsom Boulevard
UC Davis Department Of Neurology
Sacramento, CA 95816Phone+1 916-734-3588Fax+1 916-734-7188
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1971 - 1975
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1969 - 1971
Johns Hopkins University School of MedicineClass of 1969
Certifications & Licensure
NY State Medical License 1970 - Present
CA State Medical License 1992 - 2026
IL State Medical License 1976 - 1993
FL State Medical License 1973 - 1989
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Treatment of Lambert-Eaton Syndrome With 3,4 DAP
- BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel
Nature Biotechnology. 2024-12-01 - 70 citationsPrecision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel
Nature Biotechnology. 2023-09-01 - 1 citationsIntravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint in...Ge Xiong, Richard Benjamin Young, Helen Chow, Emanual Maverakis, Ricardo A Maselli
Frontiers in Oncology. 2023-01-01
Grant Support
- Development Of Animal Models Of Anti-Musk MyastheniaNational Institute Of Neurological Disorders And Stroke2010–2011
- IX International Conference On Myasthenia GravisNational Institute Of Neurological Disorders And Stroke1997
- Pathogenic Mechanisms In MyastheniaNational Institute Of Neurological Disorders And Stroke1994–1996
- Antiidiotypic Antibodies In MyastheniaNational Institute Of Neurological Disorders And Stroke1994–1995
- Anti-Idiotypic Antibodies In MyastheniaNational Institute Of Neurological Disorders And Stroke1991–1993
- Pathogenic Mechanisms In Myasthenia GravisNational Institute Of Neurological Disorders And Stroke1991–1992
- In Vivo Effects Of Antibodies Blocking Achr Function IonNational Institute Of Neurological Disorders And Stroke1991
- Core--ScientificNational Institute Of Neurological Disorders And Stroke1991
- Anti-Idiotypic Antibodies In MyastheniaNational Institute Of Neurological Disorders And Stroke1985–1991
- Scientific CoreNational Institute Of Neurological Disorders And Stroke1989–1990
- Structure/Function Analysis Of Acchr EpitopesNational Institute Of Neurological Disorders And Stroke1987–1990
- In Vivo Effects Of Antibodies Blocking Acchr Function IonNational Institute Of Neurological Disorders And Stroke1987–1990
- Pathogenic Mechanisms In Myasthenia GravisNational Institute Of Neurological Disorders And Stroke1985–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
